Synthesis and Cytokinin Activity of Two Fluoro Derivatives of N6-Isopentenyladenine
摘要:
Two derivatives of N-6-isopentenyladenine, 3 and 4, bearing either a vinylic fluorine atom or a trifluoromethyl group, were easily synthesized from known fluorinated precursors. Both derivatives 3 and 4 were found to be more active, as cytokinins, than the parent compounds zeatin (1) and N-6-isopentenyladenine (2).
Synthesis and Cytokinin Activity of Two Fluoro Derivatives of N6-Isopentenyladenine
摘要:
Two derivatives of N-6-isopentenyladenine, 3 and 4, bearing either a vinylic fluorine atom or a trifluoromethyl group, were easily synthesized from known fluorinated precursors. Both derivatives 3 and 4 were found to be more active, as cytokinins, than the parent compounds zeatin (1) and N-6-isopentenyladenine (2).
[EN] PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS<br/>[FR] DÉRIVÉS PYRROLIDINE ET LEUR UTILISATION EN TANT QUE MODULATEURS DE LA VOIE DU COMPLÉMENT
申请人:NOVARTIS AG
公开号:WO2014002052A1
公开(公告)日:2014-01-03
The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as a factor D inhibitor for the treatment of ophthalmic diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS
申请人:FLOHR Stefanie
公开号:US20150322060A1
公开(公告)日:2015-11-12
The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as a factor D inhibitor for the treatment of ophthalmic diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Two derivatives of N-6-isopentenyladenine, 3 and 4, bearing either a vinylic fluorine atom or a trifluoromethyl group, were easily synthesized from known fluorinated precursors. Both derivatives 3 and 4 were found to be more active, as cytokinins, than the parent compounds zeatin (1) and N-6-isopentenyladenine (2).